Ratings by Truist Securities (Greg Renza)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/11/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 7/7/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2026 | Nuvalent | NUVL | Downgrade | Hold (Buy) |
88.49 (123.96) |
40.08% | Details | |
| 6/9/2026 | Nurix | NRIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2026 | Bicycle Therapeutics | BCYC | Maintain | Hold (N/A) |
|
Details | ||
| 5/1/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/30/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Ascentage Pharma Group | AAPG | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | Amgen | AMGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/1/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Abivax | ABVX | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | Bicycle Therapeutics | BCYC | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2026 | Perspective Therapeutics Inc | CATX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Fulcrum Therapeutics | FULC | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2026 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | MannKind | MNKD | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Nuvation Bio Inc | NUVB | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2026 | Gilead Sciences | GILD | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2025 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2025 | Perspective Therapeutics Inc | CATX | New Coverage | Buy (N/A) |
2.09 (3.12) |
49.28% | Details | |
| 11/24/2025 | Gilead Sciences | GILD | New Coverage | Buy (N/A) |
126.64 (151.22) |
19.41% | Details | |
| 11/24/2025 | Nurix | NRIX | New Coverage | Buy (N/A) |
16.76 (25.32) |
51.07% | Details | |
| 11/24/2025 | Regeneron Pharma | REGN | New Coverage | Buy (N/A) |
755.90 (843.47) |
11.58% | Details | |
| 11/24/2025 | Amgen | AMGN | New Coverage | Hold (N/A) |
337.54 (444.12) |
31.58% | Details | |
| 11/24/2025 | Ascentage Pharma Group | AAPG | New Coverage | Buy (N/A) |
30.64 (17.36) |
-43.34% | Details | |
| 11/24/2025 | Nuvalent | NUVL | New Coverage | Buy (N/A) |
105.88 (88.49) |
-16.42% | Details | |
| 11/24/2025 | CG Oncology | CGON | New Coverage | Buy (N/A) |
42.44 (74.33) |
75.14% | Details | |
| 11/24/2025 | MannKind | MNKD | New Coverage | Buy (N/A) |
5.03 (3.96) |
-21.27% | Details | |
| 11/24/2025 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
6.99 (6.77) |
-3.15% | Details | |
| 11/24/2025 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
30.34 (22.96) |
-24.32% | Details | |
| 11/24/2025 | Fulcrum Therapeutics | FULC | New Coverage | Buy (N/A) |
11.29 (6.92) |
-38.71% | Details | |
| 11/24/2025 | Bicycle Therapeutics | BCYC | New Coverage | Hold (N/A) |
6.32 (4.24) |
-32.91% | Details | |
| 11/24/2025 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
33.99 (39.97) |
17.59% | Details | |
| 11/24/2025 | Abivax | ABVX | New Coverage | Buy (N/A) |
119.12 (114.04) |
-4.26% | Details | |
| 11/24/2025 | Agios Pharma | AGIO | New Coverage | Buy (N/A) |
25.24 (33.13) |
31.26% | Details |
